Significance of raised plasma concentrations of tissue-type plasminogen activator and plasminogen activator inhibitor in patients at risk from ischaemic heart disease
about
Hypercholesterolaemia and lipid lowering treatment do not affect the acute endogenous fibrinolytic capacity in vivoAcute inhibitory effect of alcohol on fibrinolysis.Increased tissue plasminogen activator levels in patients with nonvalvular atrial fibrillationAre we content with lowering blood pressure alone, or should we be asking something more from the antihypertensive drugs we use?: effects of antihypertensive agents on fibrinolytic function.Plasma Biomarkers of Inflammation, Endothelial Function and Hemostasis in Cerebral Small Vessel Disease.Acute coronary syndromes: from the laboratory markers to the coronary vesselsThe Role of Hemostatic Factors in Atherosclerosis in Patients with Chronic Renal Disease.A reliable marker of endothelial cell dysfunction: does it exist?The status of plasminogen activator inhibitor-1 as a therapeutic target.Plasminogen activator inhibitor and the risk of cardiovascular disease: The Framingham Heart Study.Associations of von Willebrand factor, fibrin D-dimer and tissue plasminogen activator with incident coronary heart disease: British Women's Heart and Health cohort study.Ozone exposure is associated with acute changes in inflammation, fibrinolysis, and endothelial cell function in coronary artery disease patients.
P2860
Q28343977-6220DBA2-301F-4DC1-812F-0D7AA595A680Q31899159-DF4B2FA8-9ED0-46B6-BC28-800F701BDB21Q34025555-3E40AB4B-DC60-4802-82D4-6CDF8AD301B5Q35816401-275519E6-D5B6-49E8-9A96-7527A44AF053Q36180009-C0413176-C522-4342-9E30-A60D51126520Q37277926-D7B9E8D2-8BEA-4169-B748-743B8EEB6A79Q38956831-9C81775B-C4C1-46F2-BDB9-CC55D3C0C0E8Q40401880-FC6BF573-7EA4-47A0-8957-1DDDBAAB0C7FQ40894566-BFBF3B0E-0D0D-4728-843F-FCB31E239F08Q40898533-5296CCD0-CFCB-4DDC-8F4E-560C6CC4F4D1Q46958895-095CA006-2F27-4646-9D15-A50506B9732DQ47130495-A585C406-037C-474A-8A13-7A52E9DAE064
P2860
Significance of raised plasma concentrations of tissue-type plasminogen activator and plasminogen activator inhibitor in patients at risk from ischaemic heart disease
description
1994 nî lūn-bûn
@nan
1994 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Significance of raised plasma ...... k from ischaemic heart disease
@ast
Significance of raised plasma ...... k from ischaemic heart disease
@en
type
label
Significance of raised plasma ...... k from ischaemic heart disease
@ast
Significance of raised plasma ...... k from ischaemic heart disease
@en
prefLabel
Significance of raised plasma ...... k from ischaemic heart disease
@ast
Significance of raised plasma ...... k from ischaemic heart disease
@en
P2860
P356
P1476
Significance of raised plasma ...... k from ischaemic heart disease
@en
P2093
P2860
P304
P356
10.1136/HRT.71.6.504
P577
1994-06-01T00:00:00Z